跳至主要内容
临床试验/NCT07118579
NCT07118579招募中4 期

Effects of Remimazolam and Ciprofol Total Intravenous Anesthesia on Perioperative Respiratory Adverse Events in Pediatric Tonsillectomy and Adenoidectomy: A Randomized Controlled Study

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2025年9月23日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
114
试验地点
1
主要终点
The incidence of perioperative respiratory adverse events

研究概览

简要总结

To observe the effects of remimazolam versus ciprofol TIVA on PRAE in pediatric tonsillectomy and adenoidectomy.

详细描述

To observe the effects of remimazolam versus ciprofol TIVA on PRAE in pediatric tonsillectomy and adenoidectomy, aiming to enhance surgical safety and improve postoperative outcomes in pediatric patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged 2-12 years
  • ASA physical status I-II
  • Body mass index (BMI): 14-28 kg/m²
  • Scheduled for elective tonsillectomy with or without adenoidectomy
  • Signed informed consent by legal guardian(s) and assent by children (≥8 years old)

排除标准

  • History of severe pulmonary diseases (e.g., asthma, bronchiectasis, severe OSA)
  • Previous episodes of significant PRAEs
  • Documented drug allergies (e.g., to remimazolam, propofol, or ciprofol)
  • Comorbidities including: Uncorrected congenital heart disease, neuromuscular disorders, Developmental delay, Abnormal hepatic/renal function
  • Preoperative moderate-to-severe respiratory infections requiring surgery postponement
  • Recent participation in other clinical trials

研究组 & 干预措施

Propofol group

Active Comparator

Anesthesia induction (2-3 mg/kg) + Anesthesia maintenance (6-10 mg/kg/h)

干预措施: Propofol (Drug)

Remimazolam group

Experimental

Anesthesia induction (0.3-0.5 mg/kg) + Anesthesia maintenance (1-3 mg/kg/h)

干预措施: Remimazolam (Drug)

Ciprofol group

Experimental

Anesthesia induction (0.4-0.5 mg/kg) + Anesthesia maintenance (0.8-1.2 mg/kg/h)

干预措施: Ciprofol (Drug)

结局指标

主要结局

The incidence of perioperative respiratory adverse events

时间窗: 5days

The perioperative respiratory adverse events including: laryngospasm, bronchospasm, severe cough, oxygen desaturation, airway obstruction.

次要结局

  • Anesthesia duration(1 day)
  • Emergence time(1 day)
  • Extubation time(1 day)
  • PACU stay duration(1 day)
  • The modified Aldrete score(1 day)
  • doses of drugs(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

aijun xu

Professor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验